| 21.64 Data as of May 20 |  -0.69 / -3.09%Today’s Change | 9.95 Today|||52-Week Range 26.50 | +91.84% Year-to-Date |
| 5 Stocks Rising on Unusual Volume May 20 / TheStreet.com |
| Previous close | 22.33 |
| Today’s open | 22.36 |
| Day’s range | -- - -- |
| Volume | 90,772 |
| Average volume (3 months) | 118,641 |
| Market cap | $433.7M |
| Dividend yield | -- |
| Earnings growth (last year) | -49.33% |
| Earnings growth (this year) | +86.46% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 10.48 |
| Today’s change | Today’s % change | |
|---|---|---|
| PLXProtalix Biotherapeu... | +0.04 | +0.78% |
| OSIROsiris Therapeutics ... | -0.57 | -5.06% |
| CRISCuris Inc | -0.21 | -5.10% |
| NVAXNovavax Inc | -0.03 | -1.49% |
| Next reporting date | September 6, 2013 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$32.3M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director Donald J. Santel |
Chief Financial Officer & Secretary Jeffrey S. Farrow |
Corporate headquarters South San Francisco, California |
.
